Moreover, the expression of NKp30 isoforms was linked to 10-year event-free survival in high-risk NB cohorts, and serum levels of B7-H6, a ligand of NKp30, correlated with loss of NKp30 expression, bone marrow metastases, and chemoresistance [72]. Here, NCR3 is linked to neuroblastoma.